Results     28-May-24
Announcements
Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
Sales rise 34.60% to Rs 383.20 crore
Net profit of Astrazeneca Pharma India rose 128.60% to Rs 39.48 crore in the quarter ended March 2024 as against Rs 17.27 crore during the previous quarter ended March 2023. Sales rose 34.60% to Rs 383.20 crore in the quarter ended March 2024 as against Rs 284.70 crore during the previous quarter ended March 2023.

For the full year,net profit rose 62.66% to Rs 161.51 crore in the year ended March 2024 as against Rs 99.29 crore during the previous year ended March 2023. Sales rose 29.17% to Rs 1295.53 crore in the year ended March 2024 as against Rs 1002.97 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales383.20284.70 35 1295.531002.97 29
OPM %12.8921.02 -14.2416.46 -
PBDT58.1267.76 -14 218.05190.59 14
PBT54.3663.51 -14 203.11174.33 17
NP39.4817.27 129 161.5199.29 63

Previous News
  Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:43 )
  Astrazeneca Pharma India standalone net profit rises 167.30% in the June 2023 quarter
 ( Results - Announcements 14-Aug-23   14:37 )
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine
 ( Hot Pursuit - 12-Mar-24   13:02 )
  Astrazeneca Pharma India standalone net profit declines 45.03% in the June 2021 quarter
 ( Results - Announcements 09-Aug-21   15:05 )
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
  Astrazeneca Pharma soars after receiving regulatory nod for importing Andexxa
 ( Hot Pursuit - 20-Jan-24   13:14 )
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Astrazeneca Pharma gains after DGCA approves anti-diabetic drug
 ( Hot Pursuit - 26-Sep-19   10:25 )
  Astrazeneca Pharma India AGM scheduled
 ( Corporate News - 27-May-21   14:24 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top